SCHEMBL4193685

SCHEMBL4193685

CC(=O)Oc1c(C(=O)C(C)(C)C)sc2ccc(F)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCKDK O14874 1/20 0.36
ICAM1 P05362 3/20 0.34
SELE P16581 3/20 0.34
MTNR1A P48039 2/20 0.34
MTNR1B P49286 2/20 0.34
DYRK1A Q13627 2/20 0.34
VCAM1 P19320 1/20 0.34
CMA1 P23946 2/20 0.34
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
F2 P00734 1/20 0.33
PMM2 O15305 2/20 0.33
MPI P34949 2/20 0.33
APOBEC3G Q9HC16 2/20 0.33
NPC1 O15118 1/20 0.33
MIF P14174 1/20 0.33
RAB9A P51151 1/20 0.33
PHOSPHO1 Q8TCT1 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4342850 0.79 CMA1 (0.41) BCKDKMTNR1AMTNR1BCMA1PMM2
SCHEMBL4188868 0.74 PTGDR2 (0.41) BCKDKMTNR1AMTNR1B
SCHEMBL4605894 0.71 ESR1 (0.40) CMA1KMT2ANPC1RAB9AESR1
SCHEMBL15698889 0.69 CFTR (0.43) DYRK1AMAPTKMT2ATP53KDM4E
SCHEMBL9541007 0.68 KDM4E (0.47) MAPTKMT2ATP53KDM4EALDH1A1
SCHEMBL6963675 0.68 CMA1 (0.46) BCKDKMTNR1AMTNR1BDYRK1ACMA1
SCHEMBL14293108 0.68 BCKDK (0.58) BCKDKMAPTNPC1RAB9ATP53
SCHEMBL4603763 0.68 MAOB (0.44) ICAM1SELEVCAM1MAPTKMT2A
SCHEMBL4191239 0.68 POLB (0.46) MTNR1AMTNR1BMAPTKMT2AKDM4E
SCHEMBL17149278 0.68 LMNA (0.44) ICAM1SELEVCAM1CMA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664011-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2009-02-25 EP disclosed
EP-1664011-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2006-06-07 EP disclosed
WO-2005020917-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2005-03-10 WO disclosed